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Abstract: New, practical approaches for the synthesis of α-amino (2-alkynylphenyl)- 9 
methylphosphonates and 1,2-dihydroisoquinolin-1-ylphosphonates were developed. By the 10 
propylphosphonic anhydride (T3P®)-mediated Kabachnik-Fields reaction of 2-alkynylbenzal- 11 
dehydes, aniline and dialkyl phosphites, α-amino (2-alkynylphenyl)-methylphosphonates were ob- 12 
tained selectively in high yields. The method developed is a simple operation and did not require a 13 
chromatographic separation, since the products could be isolated from the reaction mixture by a 14 
simple extraction.  At the same time, 2,3-disubstituted-1,2-dihydroisoquinolin-1-ylphosphonates 15 
could be prepared effectively from the same kinds of starting materials (2-alkynylbenzaldehydes, 16 
aniline and dialkyl phosphites) at 60 °C in a short reaction time by changing the catalyst for CuCl. 17 
Therefore, it was proved that the catalyst system applied played a crucial role in respect of the re- 18 
action outcome.  19 
Keywords: α-aminophosphonates, dihydroisoquinolin-1-ylphosphonates, multicomponent reac- 20 
tion, Kabachnik-Fields reaction, T3P® 21 
 22 
1. Introduction 23 
Organophosphorus compounds continue to receive widespread interest due to their 24 
unique significance in organic-, bio- and medicinal chemistry, as well as in the agriculture 25 
and plastic industries [1–3]. One of the major classes of organophosphorus compounds is 26 
the family of organophosphates. Among them, α-aminophosphonates, as the bioisosteres 27 
and structural analogues of natural α-amino acids, have attracted a considerable focus. 28 
They were found to be effective as enzyme inhibitors, antibiotics, antiviral, antifungal or 29 
antitumor agents, as well as pesticides [3–8]. In addition, the introduction of α-amino- 30 
phosphonates into an epoxy system can improve the flame retardant properties [9,10].  31 
Over the last years, the chemistry of heterocyclic derivatives of α-aminophosphonates 32 
have also received intensively growing attention [11–12]. Isoquinolines, including 1,2-dihy- 33 
droisoquinolines as privileged fragments, can be considered as a common structural scaf- 34 
fold in several natural products, that exhibit significant biological and pharmaceutical ac- 35 
tivities [15–17]. 36 
Multicomponent syntheses, such as the Kabachnik-Fields reaction, in which an 37 
amine, an oxo-compound and a >P(O)H derivative react with each other, are one of the 38 
most straightforward and efficient tools for the preparation of α-aminophosphonates and 39 
their heterocyclic derivatives [18–20]. Applying multicomponent reactions, the target 40 
products are usually formed in a “one-pot” manner from simple starting materials with 41 
high atom economy. The ability to use various reagents makes these reactions ideal for 42 
creating new molecular libraries, and in most cases, the principles of green chemistry also 43 
prevail to save time and energy [21,22]. 44 
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Only a few papers have been reported on the synthesis of α-amino (2-al- 45 
kynylphenyl)-methylphosphonates (1) and 1,2-dihydroisoquinolin-1-ylphosphonates (2) 46 
(Figure 1) by the three-component condensation of 2-alkynylbenzaldehydes, primary 47 
amines and dialkyl phosphites.  48 
 49 
 50 
Figure 1. General formula of α-amino (2-alkynylphenyl)-methylphosphonates (1) and 51 
1,2-dihydroisoquinolin-1-ylphosphonates (2).  52 
Wu and co-workers performed the condensation of 2-alkynylbenzaldehyde, aro- 53 
matic amines and small excess of diethyl phosphite in the presence of various catalytic 54 
systems [23–25]. It was found that in the presence of magnesium perchlorate or Lewis acid 55 
(FeCl3, In(OTf)3, Bi(OTf)3, Yb(OTf)3) in dichloroethane (DCE) at room temperature or at 56 
60 °C for 4 h, the α-amino (2-alkynylphenyl)-methylphosphonates (1) were formed 57 
[23,24], however, applying AgOTf as a catalyst in ethanol at 60 °C for 4-6 h, the cyclic 58 
phosphonates (2) were the main products of the reactions [23]. The latter derivatives (2) 59 
were also synthesized using CuI as a catalyst in DCE at 60 °C for 4 h [24] or applying a 60 
Lewis acid-type surfactant combined with a catalyst (CuSO4 and C12H25SO3Na) in water 61 
under ultrasonic conditions [25]. 62 
Recently, an enantioselective synthesis of 1,2-dihydroisoquinolin-1-ylphosphonates 63 
(2) was also reported [26]. In this case, the multicomponent reaction was catalyzed by a 64 
chiral silver spirocyclic phosphate in the presence of 5 Å molecular sieves in methyl tert- 65 
butyl ether at -10 °C for 3 days. 66 
Wu and his group also described a AgOTf-catalyzed ring closure reaction of α-amino 67 
(2-alkynylphenyl)methylphosphonate (1), which provided the cyclic derivatives (2) in 68 
moderate to good yields [27].  69 
There are two further examples for the multicomponent synthesis of 1,2-dihydroiso- 70 
quinolin-1-ylphosphonates (2) [28,29]. In one case, 2-(2-formylphenyl)ethenone was re- 71 
acted with primary amines and diethyl phosphite in the presence of CuI and 4 Å molecu- 72 
lar sieves in DCE at 70 °C for long reaction times (12-24 h) [28]. In the other case, a multi- 73 
catalytic four-component method was developed by the reaction of 2-bromobenzalde- 74 
hyde, alkynes, aromatic amines and diethyl phosphite, catalyzed by the combination of 75 
palladium and copper salts [29]. 76 
Propylphosphonic anhydride (T3P®) is a green, mild, and low toxic coupling and de- 77 
hydrating agent, which delivers remarkable advantages including broad functional group 78 
tolerance and easy work-up procedures due to the formation of water-soluble by-prod- 79 
ucts, thus, allows high purity and yield for the products [30]. Several applications have 80 
been reported using this reagent, e.g., in multicomponent reactions or in the preparation 81 
of various heterocyclic compounds [31]. 82 
In this paper, we describe simple and selective preparation methods for the synthesis 83 
of new α-amino (2-alkynylphenyl)-methylphosphonates (1), as well as novel 1,2-dihydroi- 84 
soquinolin-1-ylphosphonates (2) by the three-component reaction of 2-alkynylbenzal- 85 
dehydes, aromatic amines and dialkyl phosphites using different catalytic systems (T3P® 86 
or CuCl) (Scheme 1). There is no example in the literature of the use of T3P® in the three- 87 
component reaction mentioned.  88 
 89 




Scheme 1. Synthesis of α-amino (2-alkynylphenyl)-methylphosphonates (1) and 1,2-dihy- 91 
droisoquinolin-1-ylphosphonates (2). 92 
2. Materials and Methods 93 
2.1. General information 94 
The reactions were carried out at room temperature or under conventional heating 95 
in an oil bath under N2 atmosphere.  96 
High-performance liquid chromatography-mass spectrometry (HPLC-MS) measure- 97 
ments were performed with an Agilent 1200 liquid chromatography system coupled with 98 
a 6130 quadrupole mass spectrometer equipped with an ESI ion source (Agilent Technol- 99 
ogies, Palo Alto, CA, USA). Analysis was performed at 40 °C on a Gemini C18 column 100 
(150 mm × 4.6 mm, 3 µm; Phenomenex, Torrance, CA, USA) with a mobile phase flow rate 101 
of 0.6 mL/min. Composition of eluent A was 0.1% (NH4)(HCOO) in water; eluent B was 102 
0.1% (NH4)(HCOO) and 8% water in acetonitrile, 0–3 min 5% B, 3–13 min gradient, 13–20 103 
min 100% B. The injection volume was 2 µL. The chromatographic profile was registered 104 
at 254 nm. The MSD operating parameters were as follows: positive ionization mode, scan 105 
spectra from m/z 120 to 1000, drying gas temperature 300 °C, nitrogen flow rate 12 L/min, 106 
nebulizer pressure 60 psi, capillary voltage 4000 V. 107 
The 31P, 1H, 13C, NMR spectra were taken in CDCl3 solution on a Bruker AV-300 or 108 
DRX-500 spectrometer (Bruker AXS GmBH, Karlsruhe, Germany) operating at 121.5, 75.5 109 
and 300 or 202.4, 125.7 and 500 MHz, respectively. Chemical shifts are downfield relative 110 
to 85% H3PO4 and TMS. Non-equivalence effect was observed in 1H and 13C{1H} NMR 111 
spectra. Corresponding pairs of resonances were marked with (I) and (II). 112 
High resolution mass spectrometry measurements were performed on a Sciex Tri- 113 
pleTOF 5600+ high resolution tandem mass spectrometer equipped with a DuoSpray ion 114 
source. Electrospray ionization was applied in positive ion detection mode. Samples were 115 
dissolved in acetonitrile and flow injected into acetonitrile:water 50:50 flow. The flow rate 116 
was 0.2 mL/min. The resolution of the mass spectrometer was 35000.  117 
 118 
2.2. General Procedure for the Synthesis of α-Amino (2-Alkynylphenyl)-Methylphosphonates (3 and 5-10) 119 
To the mixture of 1 mmol of 2-alkynylbenzaldehydes (2-(p-tolylethynyl)benzaldehyde: 120 
0.22 g, 4-fluoro-2-(p-tolylethynyl)benzaldehyde: 0.24 g, 2-((4-methoxyphenyl)ethynyl)- 121 
benzaldehyde: 0.24 g, 2-((4-chlorophenyl)ethynyl)benzaldehyde: 0.24 g, 2-(phe- 122 
nylethynyl)benzaldehyde: 0.21 g), 1 mmol (0.09 mL) of aniline and 1 mmol of dialkyl phos- 123 
phites (dibutyl phosphite: 0.195 mL, dibenzyl phosphite: 0.22 mL, diethyl phosphite: 0.13 124 
mL) was added 1.0 mmol (0.6 mL) or 0.5 mmol (0.29 mL) of T3P® (50% solution in EtOAc) 125 
and stirred at 25 °C or at 60 °C. After completion of the reaction (1 h), the mixture was 126 
diluted with EtOAc (15 mL) and washed with 10% NaHCO3 solution (15 mL). The organic 127 
phase was dried (Na2SO4), filtered and concentrated. The following products were thus 128 
prepared: 129 




Dibutyl ((phenylamino)(2-(p-tolylethynyl)phenyl)methyl)phosphonate (3): Yield: 96% (0.47 g), 131 
light yellow solid; Mp: 78-79°C; 1H NMR (CDCl3) δ 0.76 (t, 3H, JHH = 7.4, CH3I), 0.84 (t, 3H, 132 
JHH = 7.4, CH3II), 1.13–1.22 (m, 2H, CH2CH3I), 1.28–1.38 (m, 4H, CH2CH3II, OCH2CH2I), 1.57– 133 
1.64 (m, 2H, OCH2CH2II), 2.38 (s, 3H, PhCH3), 3.46–3.54 (m, 1H, CHA, OCH2I), 3.80–3.87 (m, 134 
1H, CHA, OCH2II), 4.12 (q, 2H, JHH = 6.8, CHB, OCH2), 5.02 (br s, 1H, NH), 5.55 (d, 1H, 2JHP 135 
= 24.7, CHP), 6.63–6.69 (m, 3H, ArH), 7.09 (t, 2H, JHH = 7.9, ArH), 7.18 (d, 2H, JHH = 7.9, 136 
ArH), 7.21–7.30 (m, 2H, ArH), 7.46 (d, 2H, JHH = 8.1, ArH), 7.53 (d, 1H, JHH = 7.6, ArH), 7.59 137 
(d, 1H, JHH = 7.9, ArH); 13C NMR (CDCl3) δ 13.5, 13.6, 18.5, 18.7, 21.6, 32.3 (d, 3JCP = 6.0), 32.5 138 
(d, 3JCP = 5.7), 53.0 (d, 1JCP = 151.3), 66.9 (d, 2JCP = 7.2), 67.0 (d, 2JCP = 7.4), 86.5 (d, JCP = 2.2), 139 
95.3, 113.6, 118.2, 120.0, 123.6 (d, 3JCP = 6.9), 127.3 (d, 3JCP = 4.4), 127.6 (d, JCP = 3.1), 128.8 (d, 140 
JCP = 3.2), 129.2, 131.4, 131.9 (d, 3JCP = 2.3), 138.2 (d, JCP = 2.2), 138.8, 146.1 (d, 2JCP = 14.8); 31P 141 
NMR (CDCl3) δ 22.7; [M+H]+found= 490.2519, [M+H]+calculated= 490.2511. 142 
 143 
Dibenzyl ((phenylamino)(2-(p-tolylethynyl)phenyl)methyl)phosphonate (5): Yield: 93% (0.52 g), 144 
light yellow solid; Mp: 124-125°C; 1H NMR (CDCl3) δ 2.38 (s, 3H, PhCH3), 4.52 (dd, 1H, 145 
JHH = 8.0, JHH = 11.8, CHA, CH2OI), 4.84 (dd, 1H, JHH = 7.4, JHH = 11.8, CHA, CH2OII), 5.11 (d, 146 
2H, JHH = 8.2, CHB, CH2O), 5.69 (d, 1H, 2JHP = 24.9, CHP), 6.64 (d, 2H, JHH = 7.7, ArH), 6.68 147 
(t, 1H, JHH = 7.3, ArH), 7.19–7.31 (m, 10H, ArH), 7.39 (d, 2H, JHH = 8.1, ArH), 7.52 (d, 1H, 148 
JHH = 7.4, ArH), 7.62 (d, 1H, JHH = 7.8, ArH); 13C NMR (CDCl3) δ 21.6, 53.3 (d, 1JCP = 151.6), 149 
68.48 (d, 2JCP = 7.3), 68.53 (d, 2JCP = 7.1), 86.5 (d, JCP = 2.0), 95.6, 113.7, 118.4, 119.9, 123.6 (d, 150 
3JCP = 7.1), 127.4 (d, 3JCP = 4.6), 127.6, 127.8 (d, JCP = 3.1), 127.9, 128.2, 128.3, 128.4, 128.5, 128.9 151 
(d, JCP = 3.2), 129.23, 129.25, 131.5, 132.9 (d, 3JCP = 2.2), 136.0 (d, 3JCP = 6.0), 136.1 (d, 3JCP = 6.0), 152 
137.8 (d, JCP = 1.8), 138.8, 146.0 (d, 2JCP = 15.1); 31P NMR (CDCl3) δ 23.6; [M+H]+found= 588.2205, 153 
[M+H]+calculated= 588.2198. 154 
 155 
Dibutyl ((4-fluoro-2-(p-tolylethynyl)phenyl)(phenylamino)methyl)phosphonate (6): 156 
Yield: 87% (0.44 g), light yellow solid; Mp: 72-73 °C; 1H NMR (CDCl3) δ 0.78 (t, 3H, JHH = 157 
7.4, CH3I), 0.85 (t, 3H, JHH = 7.4, CH3II), 1.16–1.24 (m, 2H, CH2CH3I), 1.29–1.44 (m, 4H, 158 
CH2CH3II, OCH2CH2I), 1.58–1.64 (m, 2H, OCH2CH2II), 3.56–3.62 (m, 1H, CHA, OCH2I), 3.83– 159 
3.90 (m, 1H, CHA, OCH2II), 4.12 (q, 2H, JHH = 6.8, CHB, OCH2), 4.97 (br s, 1H, NH), 5.49 (dd, 160 
1H, 2JHP = 24.4, JHH = 4.7, CHP), 6.63 (d, 2H, JHH = 7.5, ArH), 6.68 (dd, 1H, JHH = 7.9, JHH = 6.8, 161 
ArH), 6.99 (td, 1H, JHH = 8.4, JHH = 2.7, ArH), 7.10 (dd, 2H, JHH = 7.2, JHH = 8.6, ArH), 7.19 (d, 162 
2H, JHH = 7.9, ArH), 7.23 (dd, 1H, JHH = 9.1, JHH = 1.9, ArH), 7.46 (d, 2H, JHH = 8.2, ArH), 7.55 163 
(ddd, 1H, JHH = 8.5, JHH = 5.7, JHH = 2.6, ArH); 13C NMR (CDCl3) δ 13.47, 13.55, 18.5, 18.7, 164 
21.6, 32.3 (d, 3JCP = 5.9), 32.5 (d, 3JCP = 5.9), 52.5 (d, 1JCP = 152.3), 66.95 (d, 2JCP = 7.4), 67.02 (d, 165 
2JCP = 7.1), 85.5 (dd, JCP = 1.8, JCF = 3.2), 96.2, 113.6, 116.2 (dd, JCP = 3.0, JCF = 21.7), 118.2 (d, 166 
JCP = 2.3), 118.4, 119.5, 125.2 (dd, 3JCP = 7.0, 3JCF = 9.6), 129.1 (dd, 3JCP = 4.1, 3JCF = 8.8), 129.28, 167 
129.30, 131.5, 134.2 (dd, 3JCP = 2.3, JCF = 3.2), 139.3, 145.9 (d, 2JCP = 14.7), 161.7 (dd, 3JCP = 3.3, 168 
1JCF = 247.1); 31P NMR (CDCl3) δ 22.4; [M+H]+found= 508.2424, [M+H]+calculated= 508.2417. 169 
 170 
Dibutyl ((2-((4-methoxyphenyl)ethynyl)phenyl)(phenylamino)methyl)phosphonate (7): 171 
Yield: 89% (0.45 g), light yellow oil; 1H NMR (CDCl3) δ 0.76 (t, 3H, JHH = 7.4, CH3I), 0.84 (t, 172 
3H, JHH = 7.4, CH3II), 1.13–1.22 (m, 2H, CH2CH3I), 1.28–1.39 (m, 4H, CH2CH3II, OCH2CH2I), 173 
1.57–1.64 (m, 2H, OCH2CH2II), 3.46–3.54 (m, 1H, CHA, OCH2I), 3.79–3.87 [3.83 (s, OCH3) 174 
overlapped by the multiplet of CHA, OCH2II total int. 4H), 4.12 (q, 2H, JHH = 6.8, CHB, 175 
OCH2), 5.03 (br s, 1H, NH), 5.54 (d, 1H, 2JHP = 24.7, CHP), 6.62–6.68 (m, 3H, ArH), 6.89 (d, 176 
2H, JHH = 8.8, ArH), 7.09 (dd, 2H, JHH = 7.4, JHH = 8.4, ArH), 7.20–7.29 (m, 2H, ArH), 7.49– 177 
7.58 (m, 3H, ArH), 7.58 (d, 1H, JHH = 8.0, ArH); 13C NMR (CDCl3) δ 13.5, 13.6, 18.5, 18.7, 178 
32.3 (d, 3JCP = 6.0), 32.5 (d, 3JCP = 5.8), 53.0 (d, 1JCP = 151.3), 55.4, 66.9 (d, 2JCP = 7.5), 67.0 (d, 179 
2JCP = 7.8), 85.9 (d, JCP = 2.3), 95.1, 113.6, 114.1, 115.2, 118.2, 123.7 (d, 3JCP = 6.9), 127.3 (d, 3JCP 180 
= 4.4), 127.6 (d, JCP = 3.1), 128.6 (d, JCP = 3.2), 129.2, 131.8 (d, 3JCP = 2.6), 133.0, 138.1 (d, JCP = 181 
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2.2), 146.2 (d, 2JCP = 14.7), 159.9; 31P NMR (CDCl3) δ 22.7; [M+H]+found= 506.2466, [M+H]+calcu- 182 
lated= 506.2460. 183 
 184 
Dibutyl ((2-((4-chlorophenyl)ethynyl)phenyl)(phenylamino)methyl)phosphonate (8): 185 
Yield: 97% (0.49 g), light yellow solid; Mp: 63-64 °C; 1H NMR (CDCl3) δ 0.76 (t, 3H, JHH = 186 
7.4, CH3I), 0.85 (t, 3H, JHH = 7.4, CH3II), 1.13–1.21 (m, 2H, CH2CH3I), 1.28–1.38 (m, 4H, 187 
CH2CH3II, OCH2CH2I), 1.57–1.64 (m, 2H, OCH2CH2II), 3.47–3.54 (m, 1H, CHA, OCH2I), 3.80– 188 
3.87 (m, 1H, CHA, OCH2II), 4.12 (q, 2H, JHH = 6.8, CHB, OCH2), 5.01 (br s, 1H, NH), 5.49 (d, 189 
1H, 2JHP = 24.8, CHP), 6.62 (d, 2H, JHH = 7.4, ArH), 6.67 (t, 1H, JHH = 7.3, ArH), 7.09 (dd, 2H, 190 
JHH = 7.2, JHH = 8.6, ArH), 7.22–7.27 (m, 1H, ArH), 7.28–7.37 (m, 3H, ArH), 7.47–7.51 (m, 2H, 191 
ArH), 7.53 (d, 1H, JHH = 7.6, ArH), 7.59 (d, 1H, JHH = 7.9, ArH); 13C NMR (CDCl3) δ 13.5, 192 
13.6, 18.5, 18.7, 32.3 (d, 3JCP = 6.0), 32.5 (d, 3JCP = 5.7), 53.2 (d, 1JCP = 151.5), 66.9 (d, 2JCP = 7.3), 193 
67.0 (d, 2JCP = 7.4), 88.1 (d, JCP = 2.1), 93.9, 113.6, 118.3, 121.6, 123.0 (d, 3JCP = 6.8), 127.4 (d, 194 
3JCP = 4.3), 127.7 (d, JCP = 3.0), 128.8, 129.2 (d, JCP = 3.1), 129.3, 132.0 (d, 3JCP = 2.2), 132.7, 134.7, 195 
138.5 (d, JCP = 2.2), 146.1 (d, 2JCP = 14.6); 31P NMR (CDCl3) δ 22.6; [M+H]+found= 510.1974, 196 
[M+H]+calculated= 510.1965. 197 
 198 
Dibutyl ((phenylamino)(2-(phenylethynyl)phenyl)methyl)phosphonate (9): Yield: 98% 199 
(0.47 g), light yellow solid; Mp: 97-98 °C; 1H NMR (CDCl3) δ 0.76 (t, 3H, JHH = 7.4, CH3I), 200 
0.84 (t, 3H, JHH = 7.4, CH3II), 1.13–1.22 (m, 2H, CH2CH3I), 1.28–1.40 (m, 4H, CH2CH3II, 201 
OCH2CH2I), 1.57–1.64 (m, 2H, OCH2CH2II), 3.46–3.55 (m, 1H, CHA, OCH2I), 3.79–3.87 (m, 202 
1H, CHA, OCH2II), 4.12 (q, 2H, JHH = 6.8, CHB, OCH2), 5.02 (br s, 1H, NH), 5.55 (dd, 1H, 2JHP 203 
= 24.7, JHH = 6.8, CHP), 6.63–6.69 (m, 3H, ArH), 7.09 (dd, 2H, JHH = 7.2, JHH = 8.7, ArH), 7.24– 204 
7.27 (m, 1H, ArH), 7.30 (t, 1H, JHH = 7.6, ArH), 7.35–7.39 (m, 3H, ArH), 7.52–7.61 (m, 4H, 205 
ArH); 13C NMR (CDCl3) δ 13.48, 13.55, 18.5, 18.7, 21.6, 32.3 (d, 3JCP = 6.0), 32.5 (d, 3JCP = 5.8), 206 
53.0 (d, 1JCP = 151.2), 66.9 (d, 2JCP = 7.2), 67.0 (d, 2JCP = 7.4), 87.2 (d, JCP = 2.3), 95.0, 113.6, 118.2, 207 
123.1, 123.3 (d, 3JCP = 6.9), 127.4 (d, 3JCP = 4.3), 127.7 (d, JCP = 3.2), 128.5, 128.6, 129.0 (d, JCP = 208 
3.1), 129.3, 131.5, 132.0 (d, 3JCP = 2.2), 138.4 (d, JCP = 2.2), 146.1 (d, 2JCP = 15.0); 31P NMR 209 
(CDCl3) δ 22.6; [M+H]+found= 476.2366, [M+H]+calculated= 476.2355. 210 
 211 
Diethyl ((phenylamino)(2-(phenylethynyl)phenyl)methyl)phosphonate (10): Yield: 95% 212 
(0.40 g), light yellow solid; Mp: 135-136 °C; 1H NMR (CDCl3) δ 1.05 (t, 3H, JHH = 7.1, CH3I), 213 
1.30 (t, 3H, JHH = 7.1, CH3II), 3.56–3.66 (m, 1H, CHA, OCH2I), 3.85–3.94 (m, 1H, CHA, OCH2II), 214 
4.21 (q, 2H, JHH = 7.3, CHB, OCH2), 5.01 (br s, 1H, NH), 5.55 (d, 1H, 2JHP = 24.8, CHP), 6.62– 215 
6.70 (m, 3H, ArH), 7.10 (t, 2H, JHH = 7.8, ArH), 7.22–7.28 (m, 1H, ArH), 7.30 (t, 1H, JHH = 7.5, 216 
ArH), 7.34–7.42 (m, 3H, ArH), 7.53–7.62 (m, 4H, ArH);13C NMR (CDCl3) δ 16.1 (d, 3JCP = 217 
5.8), 16.5 (d, 3JCP = 5.8), 53.2 (d, 1JCP = 151.3), 63.2 (d, 2JCP = 6.9), 63.5 (d, 2JCP = 7.2), 87.1 (d, JCP 218 
= 2.1), 95.1, 113.6, 118.3, 123.1, 123.4 (d, 3JCP = 6.9), 127.4 (d, 3JCP = 4.4), 127.7 (d, JCP = 3.1), 219 
128.5, 128.6, 129.0 (d, JCP = 3.1), 129.3, 131.5, 132.1 (d, 3JCP = 2.3), 138.3 (d, JCP = 2.4), 146.1 (d, 220 
2JCP = 14.8); 31P NMR (CDCl3) δ 22.7; [M+H]+found= 420.1736, [M+H]+calculated= 420.1729. 221 
 222 
2.3. General Procedure for the Synthesis of 1,2-dihydroisoquinolin-1-ylphosphonates (4 and 11-18) 223 
To the mixture of 2-alkynylbenzaldehydes [(2-(p-tolylethynyl)benzaldehyde: 1 mmol (0.22 224 
g) or 1.2 mmol (0.26 g), 4-fluoro-2-(p-tolylethynyl)benzaldehyde: 1.2 mmol (0.29 g), 2-((4- 225 
methoxyphenyl)ethynyl)benzaldehyde: 1.2 mmol (0.29 g), 2-((4-chloro- 226 
phenyl)ethynyl)benzaldehyde: 1.2 mmol (0.29 g), 2-(phenylethynyl)benzaldehyde: 1.2 227 
mmol (0.25 g)], amine [(aniline: 1 mmol (0.09 mL), 1.2 mmol (0.11 mL), p-anisidine: 1.2 228 
mmol (0.15 g), 4-chloroaniline: 1.2 mmol (0.15 g) and 1 mmol of dialkyl phosphites (dibu- 229 
tyl phosphite: 0.195 mL, dimethyl phosphite: 0.09 mL, diethyl phosphite: 0.13 mL) was 230 
added copper catalyst [0.05 mmol (5 mg) or 0.10 mmol (10 mg) of CuCl, 0.10 mmol (25 231 
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mg) CuSO4·5H2O, 0.10 mmol (12 mg) of CuBr or 0.10 mmol (19 mg) of CuI) in 1 mL of 232 
acetonitrile under N2 atmosphere. The mixture was stirred at 60 °C. The volatile compo- 233 
nents were removed in vacuum, and the residue was analysed by 31P NMR spectroscopy 234 
and by HPLC-MS. The 1,2-dihydroisoquinolin-1-ylphosphonates were obtained after col- 235 
umn chromatography using silica gel as the absorbent and dichloromethane:methanol 236 
(99:1) as the eluent. The following products were thus prepared: 237 
 238 
Dibutyl (2-phenyl-3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phosphonate (4): Yield: 79% 239 
(0.39 g), yellow oil; 1H NMR (CDCl3) δ 0.83 (t, 3H, JHH = 7.5, CH3I), 0.84 (t, 3H, JHH = 7.3, 240 
CH3II), 1.23–1.34 (m, 4H, CH2CH3), 1.47–1.59 (m, 4H, OCH2CH2), 2.27 (s, 3H, PhCH3), 3.79– 241 
3.91 (m, 2H, OCH2I), 3.91–3.98 (m, 1H, CHA, OCH2II), 3.98–4.06 (m, 1H, CHB, OCH2II), 5.44 242 
(d, 1H, 2JHP = 18.8, CHP), 6.46 (s, 1H, ArH), 6.82–6.88 (m, 1H, ArH), 7.03 (d, 2H, JHH = 7.6, 243 
ArH), 7.05–7.20 (m, 7H, ArH), 7.20–7.27 (m, 1H, ArH), 7.46 (d, 2H, JHH = 7.7, ArH); 13C 244 
NMR (CDCl3) δ 13.50, 13.53, 18.60, 18.62, 21.2, 32.56 (d, 3JCP = 5.4), 32.59 (d, 3JCP = 5.7), 64.2 245 
(d, 1JCP = 163.6), 66.1 (d, 2JCP = 7.4), 66.4 (d, 2JCP = 7.6), 111.6, 122.2, 122.63, 122.65, 124.2 (d, 246 
JCP = 2.7), 125.7 (d, JCP = 3.2), 126.4 (d, JCP = 2.0), 127.2 (d, 2JCP = 5.9), 127.5, 128.2 (d, JCP = 3.1), 247 
128.4, 129.0, 133.2 (d, 3JCP = 3.3), 134.5, 137.7, 142.0 (d, 3JCP = 1.8), 147.8 (d, 3JCP = 7.2); 31P 248 
NMR (CDCl3) δ 20.8; [M+H]+found= 490.2517, [M+H]+calculated= 490.2511. 249 
 250 
Dimethyl (2-phenyl-3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phosphonate (11): Yield: 86% 251 
(0.35 g), yellow oil; 1H NMR (CDCl3) δ 2.27 (s, 3H, PhCH3), 3.61 (d, 3H, JHH = 10.5, OCH3I), 252 
3.68 (d, 3H, JHH = 10.6, OCH3II), 5.47 (d, 1H, 2JHP = 18.7, CHP), 6.50 (s, 1H, ArH), 6.84–6.89 253 
(m, 1H, ArH), 7.03–7.21 (m, 9H, ArH), 7.22–7.27 (m, 1H, ArH), 7.46 (d, 2H, JHH = 8.2, ArH); 254 
13C NMR (CDCl3) δ 21.2, 53.27 (d, 2JCP = 9.5), 53.32 (d, 2JCP = 8.9), 64.0 (d, 1JCP = 163.3), 111.4, 255 
122.5, 122.80, 122.82, 124.3 (d, JCP = 2.7), 125.4 (d, JCP = 3.2), 126.6 (d, JCP = 2.1), 127.2 (d, 2JCP = 256 
6.0), 127.6, 128.4 (d, JCP = 3.1), 128.6, 129.1, 133.2 (d, 3JCP = 3.2), 134.4, 138.0, 142.2 (d, 3JCP = 257 
1.8), 147.7 (d, 3JCP = 7.1); 31P NMR (CDCl3) δ 23.2; [M+H]+found= 406.1580, [M+H]+calculated= 258 
406.1572. 259 
 260 
Diethyl (2-phenyl-3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phosphonate (12): Yield: 83% 261 
(0.36 g), yellow oil; 1H NMR (CDCl3) δ 1.19 (t, 3H, JHH = 7.0, CH3I), 1.23 (t, 3H, JHH = 7.2, 262 
CH3II), 2.27 (s, 3H, PhCH3), 3.86–3.98 (m, 2H, OCH2I), 3.98–4.04 (m, 1H, CHA, OCH2II), 4.06– 263 
4.13 (m, 1H, CHB, OCH2II), 5.43 (d, 1H, 2JHP = 18.8, CHP), 6.47 (s, 1H, ArH), 6.82–6.88 (m, 264 
1H, ArH), 7.04 (d, 2H, JHH = 7.8, ArH), 7.06–7.20 (m, 7H, ArH), 7.21–7.27 (m, 1H, ArH), 7.47 265 
(d, 2H, JHH = 7.8, ArH); 13C NMR (CDCl3) δ 16.4 (d, 3JCP = 5.4), 16.5 (d, 3JCP = 5.6), 21.2, 62.5 266 
(d, 2JCP = 7.1), 62.7 (d, 2JCP = 7.5), 64.2 (d, 1JCP = 163.2), 111.5, 122.2, 122.70, 122.72, 124.2 (d, 267 
JCP = 2.7), 125.6 (d, JCP = 3.2), 126.4 (d, JCP = 2.0), 127.2 (d, 2JCP = 5.9), 127.5, 128.2 (d, JCP = 3.1), 268 
128.5, 129.0, 133.2 (d, 3JCP = 3.1), 134.5, 137.8, 142.1 (d, 3JCP = 1.1), 147.8 (d, 3JCP = 7.2); 31P 269 
NMR (CDCl3) δ 20.9; [M+H]+found=434.1894, [M+H]+calculated= 434.1885. 270 
 271 
Dibutyl (6-fluoro-2-phenyl-3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phosphonate (13): 272 
Yield: 81% (0.41 g), yellow oil; 1H NMR (CDCl3) δ 0.83 (t, 3H, JHH = 7.4, CH3I), 0.85 (t, 3H, 273 
JHH = 7.4, CH3II), 1.24–1.34 (m, 4H, CH2CH3), 1.49–1.59 (m, 4H, OCH2CH2), 2.27 (s, 3H, 274 
PhCH3), 3.84–4.05 (m, 4H, OCH2), 5.39 (d, 1H, 2JHP = 18.4, CHP), 6.38 (s, 1H, ArH), 6.79– 275 
6.89 (m, 3H, ArH), 7.01–7.12 (m, 7H, ArH), 7.49 (d, 2H, JHH = 8.3, ArH); 13C NMR (CDCl3) 276 
δ 13.5, 13.6, 18.66, 18.68, 21.2, 32.6 (d, 3JCP = 5.6), 32.7 (d, 3JCP = 5.7), 63.8 (d, 1JCP = 164.9), 66.3 277 
(d, 2JCP = 7.3), 66.4 (d, 2JCP = 7.6), 110.5, (dd, JCP = 2.5, 2JCF = 22.6), 110.6 (d, JCP = 2.4), 113.0 278 
(dd, JCP = 1.8, 2JCF = 22.4), 121.2 (t, JCP = 3.0), 122.6, 122.91, 122.93, 127.7, 128.57, 128.60 (dd, 279 
2JCP = 6.0, JCF = 8.7), 129.1, 134.1, 135.2 (d, 3JCP = 3.1, 3JCF = 8.7), 138.2, 143.3 (d, 3JCP = 1.7), 147.7 280 
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(d, 3JCP = 6.9), 162.9 (dd, JCP = 3.1, 1JCF = 244.9); 31P NMR (CDCl3) δ 20.5; [M+H]+found= 508.2424, 281 
[M+H]+calculated= 508.2417. 282 
 283 
Dibutyl (3-(4-methoxyphenyl)-2-phenyl-1,2-dihydroisoquinolin-1-yl)phosphonate (14): 284 
Yield: 80% (0.40 g), yellow oil; 1H NMR (CDCl3) δ 0.82 (t, 3H, JHH = 7.4, CH3I), 0.84 (t, 3H, 285 
JHH = 7.4, CH3II), 1.24–1.33 (m, 4H, CH2CH3), 1.48–1.58 (m, 4H, OCH2CH2), 3.74 (s, 3H, 286 
PhOCH3), 3.81–4.02 (m, 4H, OCH2), 5.42 (d, 1H, 2JHP = 18.9, CHP), 6.41 (s, 1H, ArH), 6.75 287 
(d, 2H, JHH = 8.7, ArH), 6.83–6.87 (m, 1H, ArH), 7.05–7.18 (m, 7H, ArH), 7.20–7.25 (m, 1H, 288 
ArH), 7.49 (d, 2H, JHH = 8.8, ArH); 13C NMR (CDCl3) δ 13.56, 13.59, 18.60, 18.67, 32.61 (d, 289 
3JCP = 5.6), 32.64 (d, 3JCP = 5.6), 55.2, 64.2 (d, 1JCP = 163.5), 66.2 (d, 2JCP = 7.3), 66.4 (d, 2JCP = 7.7), 290 
111.0, 113.7, 122.2, 122.75, 122.77, 124.1 (d, JCP = 2.7), 125.7 (d, JCP = 3.2), 126.3 (d, JCP = 2.2), 291 
127.2 (d, 2JCP = 5.9), 128.2 (d, JCP = 3.2), 128.5, 128.9, 129.4, 133.3 (d, 3JCP = 3.1), 141.8 (d, 3JCP = 292 
1.8), 147.9 (d, 3JCP = 7.2), 159.4; 31P NMR (CDCl3) δ 20.9; [M+H]+found= 506.2469, [M+H]+calcu- 293 
lated= 506.2460. 294 
 295 
Dibutyl (3-(4-chlorophenyl)-2-phenyl-1,2-dihydroisoquinolin-1-yl)phosphonate (15): 296 
Yield: 82% (0.42 g), yellow oil; 1H NMR (CDCl3) δ 0.82 (t, 3H, JHH = 7.3, CH3I), 0.84 (t, 3H, 297 
JHH = 7.5, CH3II), 1.24–1.33 (m, 4H, CH2CH3), 1.47–1.59 (m, 4H, OCH2CH2), 3.81–4.02 (m, 298 
2H, OCH2), 5.41 (d, 1H, 2JHP = 18.8, CHP), 6.48 (s, 1H, ArH), 6.87 (t, 1H, JHH = 7.1, ArH), 7.04 299 
(d, 2H, JHH = 8.1, ArH), 7.08–7.13 (m, 3H, ArH), 7.14–7.22 (m, 4H, ArH), 7.23–7.28 (m, 1H, 300 
ArH), 7.50 (d, 2H, JHH = 8.6, ArH); 13C NMR (CDCl3) δ 13.5, 13.6, 18.65, 18.66, 32.6 (d, 3JCP = 301 
5.4), 32.7 (d, 3JCP = 5.7), 64.1 (d, 1JCP = 163.8), 66.2 (d, 2JCP = 7.4), 66.4 (d, 2JCP = 7.7), 112.8, 302 
122.58, 122.62, 122.64, 124.5 (d, JCP = 2.7), 125.8 (d, JCP = 3.2), 126.9 (d, JCP = 2.0), 127.3 (d, 2JCP 303 
= 5.9), 128.3 (d, JCP = 3.2), 128.6, 128.7, 128.8, 132.8 (d, 3JCP = 3.3), 133.6, 136.0, 140.9 (d, 3JCP = 304 
1.8), 147.5 (d, 3JCP = 7.1); 31P NMR (CDCl3) δ 20.7; [M+H]+found= 510.1974, [M+H]+calculated= 305 
510.1965. 306 
 307 
Dibutyl (2,3-diphenyl-1,2-dihydroisoquinolin-1-yl)phosphonate (16): Yield: 80% (0.38 g), 308 
yellow oil; 1H NMR (CDCl3) δ 0.86 (t, 3H, JHH = 7.1, CH3I), 0.87 (t, 3H, JHH = 7.2, CH3II), 1.27– 309 
1.36 (m, 4H, CH2CH3), 1.50–1.62 (m, 4H, OCH2CH2), 3.84–4.07 (m, 4H, OCH2), 5.48 (d, 1H, 310 
2JHP = 18.8, CHP), 6.53 (s, 1H, ArH), 6.85–6.91 (m, 1H, ArH), 7.08–7.30 (m, 11H, ArH), 7.61 311 
(d, 2H, JHH = 7.7, ArH); 13C NMR (CDCl3) δ 13.5, 13.6, 18.65, 18.66, 32.61 (d, 3JCP = 5.7), 32.63 312 
(d, 3JCP = 5.6), 64.2 (d, 1JCP = 163.6), 66.2 (d, 2JCP = 7.2), 66.4 (d, 2JCP = 7.7), 112.4, 122.3, 122.63, 313 
122.65, 124.3 (d, JCP = 2.8), 125.8 (d, JCP = 3.5), 126.6 (d, JCP = 2.6), 127.3 (d, 2JCP = 6.0), 127.6, 314 
127.9.5, 128.26, 128.27 (d, JCP = 2.3), 128.5, 133.1 (d, 3JCP = 3.6), 137.4, 142.0 (d, 3JCP = 1.9), 147.8 315 
(d, 3JCP = 7.7); 31P NMR (CDCl3) δ 20.8; [M+H]+found= 476.2362, [M+H]+calculated= 476.2355. 316 
 317 
3. Results and Discussion 318 
First, the model reaction of 2-(p-tolylethynyl)benzaldehyde (A), aniline (B) and dibu- 319 
tyl phosphite (C) was studied (Table 1). Performing the three-component condensation 320 
without any catalyst in acetonitrile at 60 °C for 4 h, the conversion was only 52%, and the 321 
dibutyl ((phenylamino)(2-(p-tolylethynyl)phenyl)methyl)phosphonate (3) was the main 322 
product, however, 2% of dibutyl (2-phenyl-3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phos- 323 
phonate (4) was also formed (Table 1, Entry 1). Repeating the reaction in the presence of 324 
half equivalent of propylphosphonic anhydride (T3P®) as the condensing agent, at room 325 
temperature for 1 h, it was found that a conversion of 70% could be already reached, and 326 
product 3 was formed selectively (Table 1, Entry 2). Increasing the amount of T3P® for one 327 
equivalent, resulted in a similar conversion (71%) after 30 min (Table 1, Entry 3). Using 328 
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one equivalent of T3P® and applying a reaction time of 1 h, the reaction was complete, and 329 
phosphonate 3 was formed in a ratio of 100% (Table 1, Entry 4).  330 
Our aim was also to accomplish the synthesis of dibutyl (2-phenyl-3-(p-tolyl)-1,2-di- 331 
hydroisoquinolin-1-yl)phosphonate (4), therefore the three-component reaction was in- 332 
vestigated in the presence of various copper catalysts (Table 1, Entries 5-9). Carrying out 333 
the condensation using 5 mol% of CuSO4·5H2O at 60 °C for 1 h under solvent-free condi- 334 
tions, the cyclic phosphonate (4) was the main product (68%), however, 5% of phospho- 335 
nate 3 and 27% of unreacted dibutyl phosphite (C) was also detected in the reaction mix- 336 
ture (Table 1, Entry 5). Repeating this reaction in acetonitrile, the condensation was much 337 
more efficient, since 86% of cyclic phosphonate (4) was formed (Table 1, Entry 6). Apply- 338 
ing CuI, CuBr or CuCl as catalysts, the results obtained were somewhat similar, but CuCl 339 
was proved to be the most effective (Table 1, Entries 7-9). To improve the conversion, an 340 
experiment was performed in the presence of 10 mol% of CuCl at 60 °C for 1 h, and an- 341 
other at a higher temperature of 80 °C for 1 h, as well as a third at 60 °C for 1.5 h (Table 1, 342 
Entries 10-12). It was found that the conversion of each reaction did not change signifi- 343 
cantly. Next, the condensation was carried out using a small excess of aniline in the pres- 344 
ence of 5 mol% of CuCl at 60 °C for 1 h, and the reaction was almost complete (Table 1, 345 
Entry 12). Repeating the condensation with 1.2 equivalents of acetylene and aniline under 346 
the same conditions, 100% of cyclic phosphonate (4) was formed (Table 1, Entry 14).  347 
 348 












C 3 4 
1 1:1:1 − MeCN 60 4 48 50 2 
2 1:1:1 0.5 equiv T3P® − 25 1 30 70 0 
3 1:1:1 1 equiv T3P® − 25 0.5 29 71 0 








MeCN 60 1 14 0 86 
7 1:1:1 5 mol% CuI MeCN 60 1 12 0 88 
8 1:1:1 5 mol% CuBr MeCN 60 1 13 0 87 
9 1:1:1 5 mol% CuCl MeCN 60 1 9 0 91 
10 1:1:1 10 mol% CuCl MeCN 60 1 9 0 91 
11 1:1:1 5 mol% CuCl MeCN 80 1 8 0 92 
12 1:1:1 5 mol% CuCl MeCN 60 1.5 8 0 92 
13 1:1.2:1 5 mol% CuCl MeCN 60 1 5 0 95 
14 1.2:1.2:1 5 mol% CuCl MeCN 60 1 0 0 100 
aDetermined by 31P NMR. 352 
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In the next round, the T3P®-promoted Kabachnik-Fields reaction was carried out 353 
starting from various 2-alkynylbenzaldehydes, aniline and dialkyl phosphites under the 354 
optimized conditions (1 equiv of T3P®, 25 °C, 1 h) (Table 2). The dibutyl ((phenylamino)(2- 355 
(p-tolylethynyl)phenyl)methyl)phosphonate (3) was isolated from the experiment marked 356 
by Table 1, Entry 4 in a yield of 96% after the extraction. Performing the condensation of 357 
(2-(p-tolylethynyl)benzaldehyde with aniline and dibenzyl phosphite, compound 5 was 358 
synthesized in a yield of 93%. The three-component reaction of aniline and dibutyl phos- 359 
phite was also carried out with 4-fluoro-2-(p-tolylethynyl)-, 2-((4-methoxy- 360 
phenyl)ethynyl)- and 2-((4-chlorophenyl)ethynyl)benzaldehyde, as well as 2-(phe- 361 
nylethynyl)benzaldehyde, and the corresponding α-aminophosphonates (6-9) were ob- 362 
tained in yields of 87-98%. The reactions of 2-alkynylbenzaldehydes containing an elec- 363 
tron donating group, such as methyl or methoxy group, on the phenyl ring, resulted in 364 
slightly lower yields (87% or 89%, respectively). In contrast, α-amino (2-alkynylphenyl)- 365 
methylphosphonates bearing a 4-chloro substituent on the phenyl ring (9) or the 366 
unsubstituted derivatives (10) were isolated in excellent yields. Finally, the condensation of 367 
2-(phenylethynyl)benzaldehyde and aniline was carried out with diethyl phosphite, and 368 
the result obtained was similar to that of the reaction performed with dibutyl phosphite.  369 
In contrast to previous reports, where magnesium perchlorate [23] or Lewis acids 370 
[24] were used as catalysts, the T3P®-mediated method developed is a new approach for 371 
the synthesis of α-amino (2-alkynylphenyl)-methylphosphonates, which applies green, 372 
low toxic additive and milder reaction conditions (25 °C, 1 h). Altogether seven new de- 373 
rivatives were prepared in high yields and characterized by 31P, 1H, and 13C NMR spec- 374 
troscopy, as well as by HRMS. (Copies of 31P, 1H, and 13C NMR spectra for all compounds 375 
synthesized are presented in the Supplementary Materials.) 376 
 377 
Table 2. T3P®-mediated condensation of 2-alkynylbenzaldehydes, aniline and dialkyl 378 
phosphites. 379 
 380 
aIsolated yield. 381 




The formation of α-amino (2-alkynylphenyl)-methylphosphonates by the T3P®-pro- 383 
moted Kabachnik–Fields reaction can be explained by the proposed mechanism shown in 384 
Scheme 2. First, by the reaction of 2-alkynylbenzaldehyde and aniline, imine III is formed 385 
via adduct I. This condensation may be promoted by T3P® to afford imine III along with 386 
tripropyl triphosphonic acid (QOH) as the by-product. The dehydration may take place 387 
via adduct II. In the next step, imine III reacts with the dialkyl phosphite in a nuchleo- 388 
philic addition, and after a protonation by T3P.H2O, the phosphonium salt V formed is 389 
stabilized by an Arbuzov fission to furnish α-amino (2-alkynylphenyl)-methylphospho- 390 





Scheme 2. Proposed mechanism for the T3P®-mediated synthesis of α-amino (2-al- 396 
kynylphenyl)-methylphosphonates. 397 
In the next series of experiments, the CuCl-catalyzed special Kabachnik-Fields reac- 398 
tion of 2-alkynylbenzaldehydes, aniline and dialkyl phosphites was extended using the 399 
optimized conditions (5 mol% CuCl, MeCN, 60 °C, 1 h) (Table 3). The dibutyl (2-phenyl- 400 
3-(p-tolyl)-1,2-dihydroisoquinolin-1-yl)phosphonate (4) was isolated from the experiment 401 
marked by Table 1, Entry 14 in a yield of 79% after column chromatography. The conden- 402 
sation of (2-(p-tolylethynyl)benzaldehyde and aniline was also carried out with dimethyl 403 
or diethyl phosphite as the P-reagent, and the (2-phenyl-3-(p-tolyl)-1,2-dihydroisoquino- 404 
lin-1-yl)phosphonates (11 and 12) were obtained in yields of 86% and 83%, respectively. 405 
Performing the three-component reaction of aniline and dibutyl phosphite with 4-fluoro- 406 
2-(p-tolylethynyl)-, 2-((4-methoxyphenyl)ethynyl)- and 2-((4-chlorophenyl)ethynyl)ben- 407 
zaldehyde, as well as 2-(phenylethynyl)benzaldehyde, the corresponding dialkyl (2-phe- 408 
nyl-3-aryl-1,2-dihydroisoquinolin-1-yl)phosphonates (13-16) were isolated in yields of 80- 409 
82% after column chromatography. 410 
In contrast to previous reports, which were detailed in the literature part [23-26], our 411 
CuCl-catalyzed approach for the preparation of 2,3-disubstituted-1,2-dihydroisoquinolin- 412 
1-ylphosphonates utilizes small excess of 2-alkynylbenzaldehydes and aniline, less 413 
amount of catalyst, acetonitrile solvent, reaction temperature of 60 °C and shorter reaction 414 
time (1 h). Altogether seven new derivatives were synthesized in good yields (79-86%), 415 
and characterized by 31P, 1H, and 13C NMR spectroscopy, as well as by HRMS. (Copies of 416 
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31P, 1H, and 13C NMR spectra for all compounds synthesized are presented in the Supple- 417 
mentary Materials.) 418 
 419 
Table 3. CuCl-Catalyzed condensation of 2-alkynylbenzaldehydes, aniline and dialkyl 420 
phosphites. 421 
 422 
aIsolated yield. 423 
The formation of 1,2-dihydroisoquinolin-1-ylphosphonates (2) by the CuCl-cata- 424 
lyzed three-component reaction can be explained by the mechanism shown in Scheme 3. 425 
First, by the Kabachnik-Fields reaction of 2-alkynylbenzaldehyde, aniline and dialkyl 426 
phosphite, α-aminophosphonate VI is formed. Then, the CuCl catalyst activates the triple 427 
bond for the intramolecular nucleophile attack of the amino group. This ring closure step 428 
results in an organocopper cyclic ammonium salt VII, which is stabilized by a deprotona- 429 
tion/protonation step (parallelly losing the CuCl unit) to form the 1,2-dihydroisoquinolin- 430 
1-ylphosphonate (2). 431 
 432 
 433 
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Scheme 3. Proposed mechanism for the CuCl-catalyzed synthesis of 1,2-dihydroisoquin- 434 
olin-1-ylphosphonates. 435 
 436 
4. Conclusions 437 
In summary, we have developed a novel approach for the synthesis of new α-amino (2- 438 
alkynylphenyl)-methylphosphonates by the T3P®-mediated three-component reaction of 439 
2-alkynylbenzaldehydes, aniline and dialkyl phosphites. The method developed has the 440 
advantages of the simple operation and mild reaction conditions, furthermore it does not 441 
require a chromatographic separation, since the products could be recovered from the 442 
reaction mixture by an extraction. Moreover, novel 2,3-disubstituted-1,2-dihydroisoquin- 443 
olin-1-ylphosphonates were synthesized by the CuCl-catalyzed condensation of the same 444 
kinds of starting materials (2-alkynylbenzaldehydes, aniline and dialkyl phosphites) at 445 
60 °C for a short reaction time (1 h). This approach is faster and cheaper compared to the 446 
literature examples, where the reactions were complete after 4-6 h using more expensive 447 
catalysts. Applying the methods developed, altogether seven α-amino (2-alkynylphenyl)- 448 
methylphosphonates and seven 2,3-disubstituted-1,2-dihydroisoquinolin-1-ylphospho- 449 
nate derivatives were synthesized in good to high yields, and fully characterized, all of 450 
them are new compounds. 451 
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